https://www.ainvest.com/news/biodesix-q4-2024-contradictions-unveiled-sales-force-expansion-ebitda-profitability-biopharma-revenue-2503/
Biodesix's Q4 2024: Contradictions Unveiled on Sales Force Expansion, EBITDA Profitability, and Biopharma Revenue
sales forcebiodesixcontradictionsunveiledexpansion
https://www.macrotrends.net/stocks/charts/BDSX/biodesix/financial-statements
Ten years of annual and quarterly financial statements and annual report data for Biodesix (BDSX). Income statements, balance sheets, cash flow statements and...
financial statementsbiodesixmacrotrends
https://www.businesswire.com/news/home/20230712545799/en/Biodesix-Announces-Publication-of-the-ORACLE-Clinical-Utility-Study-with-the-Primary-Endpoint-Demonstrating-that-the-Nodify-XL2-Test-Reduced-Unnecessary-Invasive-Procedures-on-Benign-Lung-Nodules
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that the prospective, real-wo...
oracle clinicalbiodesixannouncespublicationutility